10.04.2017 • NewsElaine Burridgechlor-alkaliBluestar

IPP and Bluestar in Chlor-alkali Pact

(c) Thomas Henderson/Getty Images
(c) Thomas Henderson/Getty Images

International Process Plants has entered an alliance with ChemChina’s Bluestar (Beijing) Chemical Machinery Co (BCMC) to supply new chlor-alkali plants that have been designed and built by the Chinese company.

The partnership will allow BCMC to gain access to the US group’s global reach in order to grow its international business. The companies said together, they will be able to provide new turnkey chlor-alkali and downstream chemical production facilities to markets around the world that they cannot reach independently.

“Our partnership with BCMC as a turnkey new technology provider allows us to work with our customers in the chlor-alkali industry to increase their cost competitiveness as well as to decrease their new capacity expansion project’s cost and lead time,” said IPP’s president, Ronald Gale.

The Chinese group has designed more than 180 plants worldwide, and its parent ChemChina holds more than 100 patents in the chlor-alkali industry. In addition, BCMC is one of only four suppliers of electrolyzers in the world and holds multiple international (including European and US) certifications and qualifications in design and manufacturing.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.